Showing results (171-180 of 565) with videos related to

Sort By:
Pageof 57
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 14, 2019
Ulcerative Colitis and Crohn's Disease Have Similar Burden and Goals for TreatmentCatherine Le Berre, Ashwin N Ananthakrishnan, Silvio Danese, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2016
Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel DiseasePaul Lochhead, Hamed Khalili, Ashwin N Ananthakrishnan, et al.
Expert Review of Gastroenterology & Hepatology|February 18, 2025
The role of immunogenicity in optimizing biological therapies for inflammatory bowel diseaseKonika Sharma, Bruno César da Silva, Stephen B Hanauer
Gastroenterology & Hepatology|October 23, 2015
Emerging Treatment Options in Mild to Moderate Ulcerative ColitisGary R Lichtenstein, Stephen B Hanauer, William J Sandborn
Current Gastroenterology Reports|November 12, 2009
Optimizing conventional therapies for inflammatory bowel diseaseMiles P Sparrow, Peter M Irving, Stephen B Hanauer
Gastroenterology & Hepatology|May 22, 2014
Risk of Biologic Therapy-Associated Progressive Multifocal Leukoencephalopathy: Use of the JC Virus Antibody Assay in the Treatment of Moderate-to-Severe Crohn's DiseaseGary R Lichtenstein, Stephen B Hanauer, William J Sandborn
Gastroenterology|September 10, 2018
Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: CommentaryStephen B Hanauer, William J Sandborn, Gary R Lichtenstein
Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Mechanisms of disease: vitamin D and inflammatory bowel diseaseWee-Chian Lim, Stephen B Hanauer, Yan Chun Li
The American Journal of Gastroenterology|January 29, 2009
Management of Crohn's disease in adultsGary R Lichtenstein, Stephen B Hanauer, William J Sandborn, et al.
Paediatric Drugs|October 8, 2025
Vedolizumab Versus Other Biologics and the Risk of Venous Thromboembolism in Patients with Pediatric-Onset Inflammatory Bowel Diseases: A Target Trial Emulation StudySerena Yun-Chen Tsai, Ashwin N Ananthakrishnan, Harland S Winter, et al.
Pageof 57